Home
Scholarly Works
Validation of Peptide Immunotherapy as a New...
Journal article

Validation of Peptide Immunotherapy as a New Approach in the Treatment of Allergic Rhinoconjunctivitis: The Clinical Benefits of Treatment with Amb a 1 Derived T cell Epitopes

Authors

Hafner RP; Salapatek A; Patel D; Larché M; Laidler P

Journal

The Journal of Allergy and Clinical Immunology, Vol. 129, No. 2,

Publisher

Elsevier

Publication Date

February 1, 2012

DOI

10.1016/j.jaci.2012.01.017

ISSN

0091-6749

Contact the Experts team